Free Trial

This company has been marked as potentially delisted and may not be actively trading.

NASDAQ:SEEL

Seelos Therapeutics (SEEL) Stock Price, News & Analysis

Seelos Therapeutics logo

About Seelos Therapeutics Stock (NASDAQ:SEEL)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
N/A
52-Week Range
N/A
Volume
2 shs
Average Volume
174,745 shs
Market Capitalization
N/A
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Receive SEEL Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Seelos Therapeutics and its competitors with MarketBeat's FREE daily newsletter.

By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

SEEL Stock News Headlines

Seelos Therapeutics Stock Price History
Take a look at this picture ...
A strange investment secret — discovered just a few short weeks before this image was taken — correctly predicted it all. Even crazier, this secret accurately called every major financial event in recent history … Now it's signaling something very scary is about to hit the market again …tc pixel
Seelos Therapeutics, Inc. (SEELQ)
Seelos Therapeutics Inc SEELQ
See More Headlines

SEEL Stock Analysis - Frequently Asked Questions

Shares of Seelos Therapeutics reverse split on Friday, September 27th 2024.The 1-16 reverse split was announced on Wednesday, September 25th 2024. The number of shares owned by shareholders was adjusted after the market closes on Thursday, September 26th 2024. An investor that had 100 shares of stock prior to the reverse split would have 6 shares after the split.

Based on aggregate information from My MarketBeat watchlists, some other companies that Seelos Therapeutics investors own include Digital Turbine (APPS), Okta (OKTA), CrowdStrike (CRWD), SoFi Technologies (SOFI) and ChargePoint (CHPT).

Company Calendar

Today
8/28/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Stock Exchange
NASDAQ
Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Current Symbol
NASDAQ:SEEL
CIK
1017491
Employees
20
Year Founded
2016

Profitability

EPS (Trailing Twelve Months)
N/A
Trailing P/E Ratio
N/A
Forward P/E Ratio
N/A
P/E Growth
N/A
Net Income
-$37.88 million
Net Margins
203.13%
Pretax Margin
203.13%
Return on Equity
N/A
Return on Assets
-431.47%

Debt

Debt-to-Equity Ratio
N/A
Current Ratio
0.08
Quick Ratio
0.08

Sales & Book Value

Annual Sales
$2.20 million
Price / Sales
0.00
Cash Flow
N/A
Price / Cash Flow
N/A
Book Value
($437.92) per share
Price / Book
N/A

Miscellaneous

Outstanding Shares
372,000
Free Float
368,000
Market Cap
N/A
Optionable
Optionable
Beta
1.94

Social Links

A Guide To High-Short-Interest Stocks Cover

MarketBeat's analysts have just released their top five short plays for September 2025. Learn which stocks have the most short interest and how to trade them. Enter your email address to see which companies made the list.

Get This Free Report

This page (NASDAQ:SEEL) was last updated on 8/28/2025 by MarketBeat.com Staff
From Our Partners